Loading organizations...
§ Private Profile · Boston, MA, USA
matchmine is a company.
Key people at matchmine.
MatchMiner provides an open-source computational platform matching cancer patients with precision medicine clinical trials using their genomic profiles. This AI-powered system efficiently identifies suitable trial options. Its core capability includes a Clinical Trial Markup Language (CTML), structuring clinical and genomic eligibility criteria for patient-trial alignment.
Established in 2016, MatchMiner emerged from the Knowledge Systems Group at the Dana-Farber Cancer Institute (DFCI). The initiative stemmed from the necessity to accelerate patient enrollment in precision cancer medicine trials. DFCI's institutional expertise provided foundational insight for developing this accessible solution, addressing a challenge in oncology research.
Clinical staff and researchers utilize the platform through patient-centric, trial-centric, and trial search modes. MatchMiner's mission centers on expediting enrollment in cancer precision medicine trials and broadening therapeutic options for patients. It seeks to optimize the connection between genomic data and clinical research, enhancing patient care.
Key people at matchmine.
Direct answer: MatchMine is a Boston-area media–discovery startup (often styled MatchMine) that built content‑recommendation and discovery products in the late 2000s; it raised institutional funding (including a $10M follow-on from the Kraft Group) and positioned itself as a recommendation engine for publishers and media companies[1].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Notes and sourcing limits